ECoG BMI for Motor and Speech Control (BRAVO)
A High-Performance ECoG-based Neural Interface for Communication and Neuroprosthetic Control
Sponsor: Karunesh Ganguly
A NA clinical study on ALS and Multiple Sclerosis, this trial is actively recruiting participants. The trial is conducted by Karunesh Ganguly and has accumulated 14 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Jul 2025 — Present [monthly]
Recruiting NA
-
Jun 2025 — Jul 2025 [monthly]
Recruiting NA
-
Sep 2024 — Jun 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
Phase: EARLY_PHASE1 → NA
▶ Show 9 earlier versions
-
Sep 2022 — Apr 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2022 — Sep 2022 [monthly]
Recruiting EARLY_PHASE1
-
Mar 2022 — Jun 2022 [monthly]
Recruiting EARLY_PHASE1
Phase: NA → EARLY_PHASE1
-
Oct 2021 — Mar 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2020 — Sep 2020 [monthly]
Recruiting NA
Phase: PHASE1 → NA
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Nov 2018 — Feb 2020 [monthly]
Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Karunesh Ganguly
- National Institute on Deafness and Other Communication Disorders (NIDCD)
For direct contact, visit the study record on ClinicalTrials.gov .